ZAI Lab announces a global licensing agreement with Sanofi for two novel compounds in chronic respiratory diseases ShanghaiZAI Lab Limited (ZAI Lab), an innovative biotech company in China, announced todayDocID: 1luRJ - View Document | |
American Thoracic Societv Guidelines for Methacholine and Exercise Challenge Testing-1999 T HIS O FFICIAL STA.TEMENT OFDocID: 1abNZ - View Document | |
Doctor explaining to childDocID: 19iQn - View Document | |
COMPARATIVE STUDY OF AUSTRALIAN AND GLOBAL GRADING OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) SEVERITYDocID: 18urm - View Document | |
Genetics and cellular mechanismsDocID: 16pA1 - View Document |